Cargando…
PTEN Hamartoma Tumor Syndrome and Immune Dysregulation()()()
Carriers of a pathogenic germline mutations in the PTEN gene, a well-known tumor suppressor gene, are at increased risk of multiple benign and malignant tumors, e.g. breast, thyroid, endometrial and colon cancer. This is called PTEN Hamartomous Tumor Syndrome (PHTS). PHTS patients may also have an i...
Autores principales: | Eissing, Marc, Ripken, Lise, Schreibelt, Gerty, Westdorp, Harm, Ligtenberg, Marjolijn, Netea-Maier, Romana, Netea, Mihai G., de Vries, I. Jolanda M., Hoogerbrugge, Nicoline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277246/ https://www.ncbi.nlm.nih.gov/pubmed/30504085 http://dx.doi.org/10.1016/j.tranon.2018.11.003 |
Ejemplares similares
-
Opportunities for immunotherapy in microsatellite instable colorectal cancer
por: Westdorp, Harm, et al.
Publicado: (2016) -
Recurrent candidiasis and early-onset gastric cancer in a patient with a genetically defined partial MYD88 defect
por: Vogelaar, Ingrid P., et al.
Publicado: (2015) -
Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome
por: Tischkowitz, Marc, et al.
Publicado: (2020) -
A review on age‐related cancer risks in PTEN hamartoma tumor syndrome
por: Hendricks, Linda A.J., et al.
Publicado: (2020) -
The yield and effectiveness of breast cancer surveillance in women with PTEN Hamartoma Tumor Syndrome
por: Hoxhaj, Alma, et al.
Publicado: (2022)